Maria Betty Grace Bontigao-Emocling: 7 Years of Purpose-Driven Leadership at Boehringer Ingelheim
Maria Betty Grace Bontigao-Emocling, Therapeutic Area Lead – Cardiovascular and Lytics Business at Boehringer Ingelheim, shared a post on LinkedIn:
”Celebrating 7 years at Boehringer Ingelheim today-and feeling incredibly proud of the journey.
Over the years, I’ve been entrusted to lead and contribute across cardiovascular, respiratory, specialty care, rare disease, and now thrombosis care.
Each therapeutic area brought new challenges, deeper responsibility, and the opportunity to grow as a leader.
I’m grateful for leaders who believed in me, mentors who challenged me, and teammates who consistently show what excellence and collaboration look like. It’s an honor to help shape patient journeys and work alongside passionate key opinion leaders who share the same purpose.
Most proud to be leading a dynamic, resilient, and high‑performing One Stroke Care Team-a group driven by impact, teamwork, and commitment to patients.
Looking forward to more milestones, growth, and meaningful impact in the years ahead.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention